Vir Biotechnology IncVIR
Price$11.18Intrinsic value$9.4216% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $9.42median of 2 methodsbased on filings through 30 Jun 2026
Market Price $11.18Price as of 30 Sep 2026
Margin of Safety -15.7%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 15.7%/yr (balance of the path).13.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 615.3%Yr 714.8%Yr 814.4%Yr 914.0%Yr 1013.5%
15.7% → 13.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1112.5%Yr 1211.4%Yr 1310.4%Yr 149.3%Yr 158.3%Yr 167.2%Yr 176.2%Yr 185.1%Yr 194.1%Yr 203.0%
13.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 11.2%
Volatility vs market (adjusted beta)1.38

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetVir Biotechnology IncVIRHealth Care
Valuation
P/E—
P/S27.0×
P/B1.8×
EV / Revenue22.9×
EV / EBITDA—
Profitability
Gross margin100.0%
Operating margin456,172.0%
Net margin-367.1%
FCF margin-297.0%
Returns
ROE-25.6%
ROA-20.7%
ROIC—
Growth
Revenue growth (YoY)-7.6%
5-yr fwd EPS growth13.5%
Financial strength
Debt / Equity0.00×
Current ratio6.04×
Altman Z-Score3.4
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.